Publications

Aktories, P., P. Petry, P. Glatz, G. Andrieux, A. Oschwald, H. Botterer, O. Gorka, D. Erny, M. Boerries, P. Henneke, O. Gross, M. Prinz, and K. Kierdorf. 2022. An improved organotypic cell culture system to study tissue-resident macrophages ex vivo. Cell Rep Methods 2: 100260. doi: 10.1016/j.crmeth.2022.100260.

Ramirez, N., S. Posadas-Cantera, N. Langer, A. C. G. de Oteyza, M. Proietti, B. Keller, F. Zhao, V. Gernedl, M. Pecoraro, H. Eibel, K. Warnatz, E. Ballestar, R. Geiger, C. Bossen, and B. Grimbacher. 2022. Multi-omics analysis of naive B cells of patients harboring the C104R mutation in TACI. Front Immunol 13: 938240. doi: 10.3389/fimmu.2022.938240.

Ehl, S., and R. Thimme. 2022. Immune-mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox. Eur J Immunol 52: 1386-1389. doi: 10.1002/eji.202250069.

Karlowitz, R., M. L. Stanifer, J. Roedig, G. Andrieux, D. Bojkova, M. Bechtel, S. Smith, L. Kowald, R. Schubert, M. Boerries, J. Cinatl, Jr., S. Boulant, and S. J. L. van Wijk. 2022. USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING. Cell Death Dis 13: 684. doi: 10.1038/s41419-022-05124-w.

Lehr, S., F. Meiss, D. Kiritsi, and L. Tsakiris. 2022. Small-Vessel Vasculitis After ST-Segment Elevation Myocardial Infarction: Clopidogrel or Amiodarone? JACC Case Rep 4: 967-971. doi: 10.1016/j.jaccas.2022.05.008.

Lehr, S., F. Felber, I. Tantcheva-Poor, C. Kessler, R. Eming, A. Nystrom, M. Rizzi, and D. Kiritsi. 2022. Occurrence of autoantibodies against skin proteins in patients with hereditary epidermolysis bullosa predisposes to development of autoimmune blistering disease. Front Immunol 13: 945176. doi: 10.3389/fimmu.2022.945176.

Hennig C, Graaf A, Petric PP, Graf L, Schwemmle M, Beer M, Harder T. Porcine Health Manag. 2022. Are pigs overestimated as a source of zoonotic influenza viruses? First published: 2022 Jun 30;8(1):30. doi: 10.1186/s40813-022-00274-x. PMID: 35773676 Free PMC article

Biavasco, F., G. Ihorst, R. Wasch, C. Wehr, H. Bertz, J. Finke, and R. Zeiser. 2022. Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract. Bone Marrow Transplant 57: 1500-1506. doi: 10.1038/s41409-022-01741-3.

Globig AM, Hipp AV, Otto-Mora P, Heeg M, Mayer LS, Ehl S, Schwacha H, Bewtra M, Tomov V, Thimme R, Hasselblatt P, Bengsch B. Nat Commun. 2022. High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature. First published: 2022 Jun 27;13(1):3688. doi: 10.1038/s41467-022-31229-z. PMID: 35760777 Free PMC article.

Tanriver, U., F. Emmerich, J. F. Hummel, B. Janigen, M. Panning, F. Arnold, and Y. Tanriver. 2022. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study. Clin Transplant 36: e14663. doi: 10.1111/ctr.14663.

Globig AM, Mayer LS, Heeg M, Andrieux G, Ku M, Otto-Mora P, Hipp A, Zoldan K, Pattekar A, Rana N, Schell C, Boerries M, Hofmann M, Neumann-Haefelin C, Kuellmer A, Schmidt A, Boettler T, Tomov V, Thimme R, Hasselblatt P, Bengsch B. Gastroenterology. 2022. Exhaustion of CD39-expressing CD8+ T cells in Crohn’s disease is linked to clinical outcome. First published: 2022 Jun 20:S0016-5085(22)00663-1. doi: 10.1053/j.gastro.2022.06.045. Online ahead of print.

Saghafi, S., F. Zandieh, M. R. Fazlollahi, C. Glocker, N. Frede, M. Buchta, L. Yang, A. H. Mahmoudi, M. Houshmand, Z. Pourpak, B. Grimbacher, and M. Moin. 2022. Confirmation of Hyperimmunoglobulin E Syndrome in Two Patients with an Ocular Problem: Detection of Two New DOCK8 Mutations. Iran J Allergy Asthma Immunol 21: 355-363. doi: 10.18502/ijaai.v21i3.9809.

Czech M, Zeiser R, Toubai T. Front Immunol. 2022. Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation. First published: 2022 Jun 8;13:948720. doi: 10.3389/fimmu.2022.948720. eCollection 2022. PMID: 35757690 Free PMC article.

Czech M, Zeiser R, Toubai T. 2022. Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation. Front Immunol. 2022 Jun 8;13:948720. doi: 10.3389/fimmu.2022.948720.

Bexte, T., J. Alzubi, L. M. Reindl, P. Wendel, R. Schubert, E. Salzmann-Manrique, I. von Metzler, T. Cathomen, and E. Ullrich. 2022. CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma. Oncoimmunology 11: 2081415. doi: 10.1080/2162402X.2022.2081415.

Kemming, J., S. Gundlach, M. Panning, D. Huzly, J. Huang, M. Lutgehetmann, S. Pischke, J. Schulze Zur Wiesch, F. Emmerich, S. Llewellyn-Lacey, D. A. Price, Y. Tanriver, K. Warnatz, T. Boettler, R. Thimme, M. Hofmann, N. Fischer, and C. Neumann-Haefelin. 2022. Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection. J Hepatol 77: 978-990. doi: 10.1016/j.jhep.2022.05.019.